KR20030025716A - Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract - Google Patents

Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract Download PDF

Info

Publication number
KR20030025716A
KR20030025716A KR1020010058894A KR20010058894A KR20030025716A KR 20030025716 A KR20030025716 A KR 20030025716A KR 1020010058894 A KR1020010058894 A KR 1020010058894A KR 20010058894 A KR20010058894 A KR 20010058894A KR 20030025716 A KR20030025716 A KR 20030025716A
Authority
KR
South Korea
Prior art keywords
extract
melanin
whitening
dried
melanin synthesis
Prior art date
Application number
KR1020010058894A
Other languages
Korean (ko)
Inventor
성창근
권일
박정훈
전형오
이종심
Original Assignee
(주)대덕바이오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)대덕바이오 filed Critical (주)대덕바이오
Priority to KR1020010058894A priority Critical patent/KR20030025716A/en
Publication of KR20030025716A publication Critical patent/KR20030025716A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: A skin whitening agent containing an extract of Dioscoreae Rhizoma is provided which exhibits a better skin whitening effect than albutin and hydroxyanisole and has no skin irritation even when used for a long period of time. CONSTITUTION: Dioscoreae Rhizoma is ground, added 5 times with 95% alcohol and extracted at 4 to 40deg.C for 48hr, the extraction process is repeated two times or more, the filtrate is dried in a rotary vacuum drier at 60deg.C. A skin whitening cosmetic contains 0.00001 to 10% by weight of the Dioscoreae Rhizoma extract, based on the dried weight of the Dioscoreae Rhizoma extract.

Description

산약 추출물을 함유하는 미백용 조성물{Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract}Whitening composition containing acid extract {Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract}

본 발명을 마 및 참마과에 속하는 식물 뿌리줄기의 주피를 제거하고 그대로 쪄서 말린 한약재인 산약의 추출물을 함유하는 미백 화장료에 관한 것이다.The present invention relates to a whitening cosmetics containing the extract of the herb, which is an herbal medicine that is dried and steamed as it is by removing the bark of the plant root stem belonging to the hemp and yam family.

멜라닌(melanin)은 자연계에 널리 분포하는 페놀류가 산화효소에 의하여 산화되어 생성된 갈색 또는 흑색의 고분자 색소로서 단백질과 강하게 결합되어 있는 생물 고분자 물질이다. 우리 주변에서 멜라닌 합성은 사과, 감자, 바나나의 잘린 표면이 공기 증에 노출되었을 때 발생하는 갈변이나, 동물의 외피, 깃털, 피부, 머리, 눈 등에서 관찰된다. 멜라닌의 과잉생산은 인체에 기미, 주근깨를 형성하고, 피부노화를 촉진하며, 피부암의 유발에 관여하는 것으로 알려졌으며, 식품에서는 채소, 과일, 생선 등의 질을 저하시키기도 한다.Melanin (melanin) is a brown or black polymer pigment produced by the oxidation of phenols widely distributed in nature is a biopolymer material strongly bound to protein. In our surroundings, melanin synthesis is observed in browning, which occurs when the cut surfaces of apples, potatoes, and bananas are exposed to pneumoconiosis, or in animal skin, feathers, skin, hair, and eyes. Overproduction of melanin is known to form blemishes, freckles, promote skin aging, and induce skin cancer in the human body. In foods, it also degrades the quality of vegetables, fruits, and fish.

멜라닌의 생합성은 주로 타이로시네이즈(tyrosianse)의 작용에 의해 이루어지는 것으로 보고되고 있다. 타이로시네이즈에 의해 생성이 촉매되는 동물멜라닌은 노란색-적갈색의 페오멜라닌(pheomelanin)과 갈색-검은색의 유멜라닌(eumelanin)으로 구분된다. 1980년대까지 멜라닌은 타이로신(L-tyrosine)으로부터 도파 (L-3,4-dihydroxy-phenylalanine)를 거치는 레이퍼-메이슨 경로(Raper-Mason pathway)를 통해 생합성되는 것으로 생각되었다. 그러나 카메야마(Kameyama)등은 포유류의 멜라닌 생성이 타이르신 이외에 타이로신 조절 단백질(TRP1), 도파크롬 타우토머레이즈 (dopachrome tautomerase), 그리고 세포가 가지고 있는 멜라닌 생성 저해인자(melanogenic inhibitor) 등의 상호작용 및 멜라닌 자극 호르몬(MSH)에 의해 조절된다는 사실을 보고하였다.The biosynthesis of melanin is reported to be mainly caused by the action of tyrosianse. Animal melanin catalyzed by tyrosinase is divided into yellow-red-brown pheomelanin and brown-black eumelanin. By the 1980s, melanin was thought to be biosynthesized via the Raper-Mason pathway from L-tyrosine to dopa (L-3,4-dihydroxy-phenylalanine). However, Kameyama et al. Noted that melanin production in mammals is not related to tyrosine, but also to tyrosine regulatory proteins (TRP1), dopachrome tautomerase, and melanogenic inhibitors that are present in cells. It has been reported that it is regulated by action and melanin stimulating hormone (MSH).

타이로시네이스 저해제로 잘 알려진 하이드록시아니솔(4-hydorxyanisol), 하이드록시인돌(5-hydoroxyindole) 및 하이드로퀴논(hydorquinone) 등은 강력한 멜라닌 생합성 저해활성을 보이지만 색소세포의 변성 또는 치사를 일으키고 세포 본래의 기능을 손상시키는 부작용을 나타내며, 코직산(5-hydorxy -2-(hydroxymethyl-v-pyrone)] ), 알부틴 (hydroquinone-β-D-gluco pyranoside) 등은 이미 상품화되어 화장품, 식품 등에 미백제로 사용되고 있지만 낮은 저해활성 , 사용중의 변색, 물질자체의 불안정성 등의 문제점이 제기되고 있으며, 대부분의 물질이 암, 돌연변이 등을 유발시키거나, 강한 독성을 나타낸다고 보고되었다. 따라서 세포독성이 낮고 멜라닌 생합성 저해활성이 높은 저해물질의 개발이 요구되고 있다.Hydroxyanisole (4-hydorxyanisol), 5-hydoroxyindole, and hydroquinone (hydorquinone), known as tyrosinase inhibitors, show potent melanin biosynthesis inhibitory activity but cause pigment cell degeneration or lethality. It has side effects that impair its original function. Kojic acid (5-hydorxy-2- (hydroxymethyl-v-pyrone)) and arbutin (hydroquinone-β-D-gluco pyranoside) are already commercialized and used as whitening agents in cosmetics and foods. Although it is used, problems such as low inhibitory activity, discoloration during use, and instability of the substance itself have been raised, and most substances have been reported to cause cancer, mutations, or have strong toxicity. Therefore, the development of inhibitors with low cytotoxicity and high melanin biosynthesis inhibitory activity is required.

현재까지 가장 널리 쓰이고 있는 미백제 탐색 방법으로는 버섯 유래의 타이로시네이즈를 이용한 타이로시네이즈 저해제 탐색법과 동물의 멜라닌 합성세포를 이용한 세포 수준에서의 평가법의 2가지가 있다. 전자는 간편하고 시간, 비용 등이 덜 드는 장점이 있으나 실제 임상에서의 효과와 일치하지 않는 경우가 많다는 단점이 있고 후자는 좀 더 종합적으로 미백제를 선별할 수는 있으나 비용이나 시간, 노력 등이 많이 든다는 단점이 있다.The two most widely used methods of searching for whitening agents are two types of screening methods: a search for tyrosinase inhibitors using mushroom-derived tyrosinase and a method for evaluation at the cellular level using melanin synthetic cells in animals. The former has the advantage of being simpler and less time-consuming and costly, but the disadvantage is that it is often inconsistent with actual clinical effects. The latter can be more comprehensively selected for whitening agents, but the cost, time and effort are much higher. The disadvantage is that it costs.

이런 단점을 보완하기 위해 본 발명자들은 멜라닌을 합성하는 진균을 이용하여 진균포자의 멜라닌 합성을 저해하는 물질을 찾아 세포의 멜라닌 생성부위에 선택적으로 작용하는 물질 탐색방법을 도입하였다.In order to compensate for this drawback, the present inventors have introduced a method of searching for substances that selectively inhibit the melanin synthesis of fungal spores using fungi synthesizing melanin and selectively acting on the melanin production site of cells.

제 1도는 산약추출물과 기존의 미백물질인 알부틴을 처리하여 쥐에서 유래한 B-16 멜라노마 셀에서의 멜라닌 생성 저해정도를 비교한 도면이다.1 is a diagram comparing the degree of inhibition of melanogenesis in B-16 melanoma cells derived from rats by treatment of the extract and arbutin, a conventional whitening substance.

본 발명은 산약추출물을 함유하는 미백화장료에 관한 것으로 보다 자세하게는 마 및 참마과에 속하는 식물 뿌리줄기의 주피를 제거하고 그대로 쪄서 말린 것을 분쇄하여 유기용매를 가한 추출물을 통상적인 기초화장료에 첨가하여 우수한 미백효과를 갖게 하는 미백 화장료에 관한 것이다.The present invention relates to a whitening cosmetic containing an acid extract, and more particularly, to remove the bark of the plant root stem belonging to the hemp and yam family, pulverized and dried as it is, to add an organic solvent extract to the conventional basic cosmetics It is about a whitening cosmetics which makes an effect.

인간에게 유효한 멜라닌생성 억제물질을 검색하기 위해 멜라닌을 합성하는 진골과, 사람의 멜라노사이트와 유사한 쥐 유래의 B-16 멜라노마 셀에서의 멜라닌 생성 저해정도를 측정하여 여러 종류의 식물추출물에 대해 미백효과를 검색하였다.Whitening of various plant extracts by measuring melanin synthesis in melanin-synthesizing melanoma to detect melanogenesis inhibitors effective in humans, and B-16 melanoma cells derived from rats similar to human melanocytes The effect was searched.

그 결과, 선약 추출물이 낮은 농도에서도 매우 우수한 멜라닌 생성 저해물질로서 인간의 피부에 도포한 결과 전혀 자극이 없음을 발견하게 되어 본 발명을 완성하게 되었다.As a result, the drug extract was found to have no irritation as a result of applying it to human skin as a very good melanin inhibitor even at low concentrations, thus completing the present invention.

실시예 1.Example 1.

본 발명의 미백화장표에 함유되는 산약추출물의 제조방법은 다음과 같다. 산약(Dioscorea Rhizoma) 1kg을 분쇄한 후 증량의 5배인 95%함수 알코올을 가하여 4-40℃에서 48시간동안 2회 이상 반복 추출한 후 와트만 42번 여과지로 여과하였다. 이 여액을 65℃에서 회전 감압 증발기로 건조하여 건조증량 56g을 얻었다.The preparation method of the acid extract contained in the whitening cosmetics of the present invention is as follows. After diluting 1 kg of Dioscorea Rhizoma, 95% functional alcohol, which is 5 times the amount of distillate, was added and extracted two times or more for 48 hours at 4-40 ° C., followed by filtration through Whatman 42 filter paper. The filtrate was dried at 65 ° C. with a rotary vacuum evaporator to obtain a dry weight increase of 56 g.

실험예 1 : 멜라닌 합성 진균에서 산약추출물의 멜라닌 합성 저해 효과 24well plate에 멜라닌을 합성하는 진균인 Asp. miser의 포자 현탁액을 포함하는 PDA배지를 넣어 굳히고 실시예 1의 추출물을 50㎕ 에탄올에 녹여 500㎍/㎖의 농도에서부터 순차적으로 희석하여 배지 표면에 직접 가한 후 37℃에서 48일간 배양하여 포자의 색소합성을 육안으로 관찰하였다. 이때 대조구로써 하이드록시아니솔을 사용하였다. 실험결과는 표 1에 나타난 바와 같다.Experimental Example 1: Inhibitory effect of medicinal herb extract on melanin synthesis in melanin synthesis fungi Asp. Put the PDA medium containing the spore suspension of the miser and solidify. The extract of Example 1 was dissolved in 50 µl ethanol and diluted sequentially from the concentration of 500 µg / ml, and directly added to the surface of the medium. Synthesis was visually observed. At this time, hydroxyanisole was used as a control. The experimental results are shown in Table 1.

[표 1]TABLE 1

산약추출물이 농도에 따른 멜라닌 합성 저해 효과가 대조구로 쓰인 하이드록시 아니솔보다 강한 효과를 나타내었을 뿐만 아니라 고농도에서도 균주의 치사현상이 없었음. 하이드록시아니솔의 경우 강한 미백효과를 나타내나 색소세포의 변성이나 치사현상등의 부작용이 있다.Inhibition of melanin synthesis according to concentration showed stronger effect than hydroxy anisole used as a control, and there was no lethality of strain at high concentration. In the case of hydroxyanisole, it shows a strong whitening effect, but has side effects such as pigment cell degeneration and lethality.

실험예 2 : 멜라노사이트(melanocyte)에서 멜라닌 생성에 대한 산약추출물의 영향Experimental Example 2 Effects of Pesticide Extracts on Melanin Production in Melanocytes

쥐에서 유래한 B16-멜라노마 세포를 5×103cells/㎖의 농도로 10% FCS(fetal calf serum)을 포함하는 DMEM(Dulbescco's Modified Eagle's Medium) 배지에 현탁시킨 후 현탁세포 5㎖을 tissuue culture flask(Falcon, Becton dickinson)에 넣고 검정시료를 농도별로 첨가한 후 5% CO2-95% 공기조건으로 37℃에서 배양한다. 4일간 배양 후 플라스크 바닥에 흡착된 세포들을 PBS(phosphate bufferd saline)로 씻은 후, 0.05% 트립신, 0.53mM EDTA 용액으로 떼어 내고 떼어낸 세포를 10분간 원심 분리하여 튜브에 모은 후 세포의 수를 측정하였다. 각 튜브의 세포 수를 일정하게 조절한 후 , 5% 트리클로로아세테이트(TCA)를 처리하여 교반하고, 원심분리하여 침전된 멜라닌을 PBS로 세척한다. 침전된 멜라닌에 1N NaOH를 처리하여 용해 시킨 후, 475nm에서 흡광도를 측정한다. 멜라닌 농도는 합성 멜라닌(sigma)의 표준농도곡선으로부터 결정하였으며 대조구로는 알부틴을 사용하였다.Rat B16-melanoma cells were suspended in DMEM (Dulbescco's Modified Eagle's Medium) medium containing 10% FCS (fetal calf serum) at a concentration of 5 × 10 3 cells / ml, followed by suspension of 5 ml of tissuue culture. Put it in a flask (Falcon, Becton dickinson) and add the assay sample by concentration and incubate at 37 ℃ with 5% CO 2 -95% air condition. After 4 days of incubation, the cells adsorbed on the bottom of the flask were washed with PBS (phosphate buffered saline), separated with 0.05% trypsin and 0.53 mM EDTA solution, the cells were centrifuged for 10 minutes, collected in a tube, and the number of cells was measured. It was. After constant adjustment of the number of cells in each tube, 5% trichloroacetate (TCA) was treated and stirred, and centrifuged to wash the precipitated melanin with PBS. 1N NaOH was dissolved in the melanin precipitated, and the absorbance was measured at 475 nm. Melanin concentration was determined from the standard concentration curve of synthetic melanin (sigma) and arbutin was used as a control.

실험결과는 표2에 나타낸바와 같다.The experimental results are shown in Table 2.

[표 2]TABLE 2

실험결과는 산약추출물이 알부틴 보다도 4배 이상 낮은 농도에서도 멜라노사이트내에서 멜라닌 합성을 억제하는 강력한 미백물질임을 나타낸다.Experimental results show that the extract is a powerful whitening agent that inhibits melanin synthesis in melanocytes even at concentrations four times lower than arbutin.

실시예 2Example 2

산약추출물을 함유한 화장료 증 유연화장수(스킨)의 처방예는 표 3과 같다.Prescription examples of cosmetic thickening cosmetics (skin) containing acid extracts are shown in Table 3.

[표 3]TABLE 3

실험예 3: 산약추출물을 함유한 제조 처방의 인체에 대한 안전성 실험Experimental Example 3: Safety experiment on the human body of the formulation containing the acid extract

본 발명에 따른 조성물 대하여 피부 자극 정도를 알아보기 위하여, 실시예 2에 따른 미백화장료에 대한 피부 첩포시험을 피검자 20명에게 실시하였다. 핀챔버(fin chamber)에 실시예 2의 유연화장수를 20㎕ 가하여 인체상박부에 24시간 첩포하고, 첩포 제거 후 1시간 이내에 피부반응을 검사하고, 다음날(48시간 후) 다시 검사하였다. 피부반응 판정은 표 4의 검사 기준에 의해 판정하고, 아래 공식에 따라 평균반응율을 계산하였다.In order to determine the degree of skin irritation with respect to the composition according to the present invention, a skin patch test on the whitening cosmetic according to Example 2 was performed on 20 subjects. 20 μl of the softening water of Example 2 was added to a fin chamber, and the patch was applied to the human upper arm for 24 hours. The skin reaction was examined within 1 hour after the patch was removed, and then examined again the following day (after 48 hours). Skin response was determined by the test criteria in Table 4, and the average response rate was calculated according to the following formula.

[표 4]TABLE 4

결과는 표 5와 같다The results are shown in Table 5.

[표 5]TABLE 5

※인체 첩포실험의 평균반응율(%)에 대한 판정 기준※ Criteria for average response rate (%) of human patch experiment

1 미만 : 무자극, 1-3미만 : 경미한 자극 3-5미만 : 약한 자극Less than 1: no stimulation, less than 1-3: slight stimulation less than 3-5: weak stimulation

5이상 : 강한 자극5 or more: strong stimulus

표 5에 의해 알 수 있듯이, 본 발명에 따른 미백 화장료 조성물은 무자극 범위에 속하므로 인체에 안전하다고 할 수 있다.As can be seen from Table 5, the whitening cosmetic composition according to the present invention can be said to be safe for the human body because it belongs to the non-irritating range.

본 발명의 산약추출물의 미백효과는 기존의 미백물질로 개발된 알부틴 및 하이드록시아니솔 등과 비교한 결과 본 발명의 산약추출물이 가장 우수한 미백효과를 나타내었으며 인체첩포 실험을 통해 본 결과 장기간 사용시 에도 피부에 자극이 없다.The whitening effect of the extract of the present invention is the most effective whitening effect of the extract of the present invention compared with the arbutin and hydroxyanisole developed as a conventional whitening material. No irritation to

Claims (3)

산약(Dioscorea rhizoma)을 분쇄한 후 증량의 5배인 95%함수 알코올을 가하여 4-40℃에서 48시간동안 2회 이상 반복 추출한 후 여과하여 이 여액을 65℃에서 회전 감압 증발기로 건조하여 얻은 산약추출물을 함유하는 미백화장료After extracting pulverized Dioscorea rhizoma, 95% functional alcohol, which is 5 times higher, was added and extracted twice or more for 48 hours at 4-40 ℃, and then filtered and the filtrate was dried by rotary evaporator at 65 ℃. Whitening cosmetics containing 제 1항에 있어서, 산약은 마 및 참마과에 속하는 식물 뿌리줄기의 주피를 제거하고 그대로 쪄서 말린 한약재임을 특징으로 하는 미백화장료The whitening cosmetic according to claim 1, wherein the acid medicine is a Chinese herb which is dried and dried as it is removed from the bark of the plant root stem belonging to the hemp and the yam family. 제 1항에 있어서, 산약추출물이 화장료의 건조중량에 대하여 0.00001 ∼10중량%의 양으로 포함되어 있는 것을 특징으로 하는 미백화장료The whitening cosmetic according to claim 1, wherein the acid extract is contained in an amount of 0.00001 to 10% by weight based on the dry weight of the cosmetic.
KR1020010058894A 2001-09-22 2001-09-22 Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract KR20030025716A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010058894A KR20030025716A (en) 2001-09-22 2001-09-22 Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010058894A KR20030025716A (en) 2001-09-22 2001-09-22 Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract

Publications (1)

Publication Number Publication Date
KR20030025716A true KR20030025716A (en) 2003-03-29

Family

ID=27725195

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010058894A KR20030025716A (en) 2001-09-22 2001-09-22 Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract

Country Status (1)

Country Link
KR (1) KR20030025716A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030061985A (en) * 2002-01-14 2003-07-23 (주)대덕바이오 Melanin synthesis inhibition compound and its composition containing stigmasterol
FR2855753A1 (en) * 2003-06-03 2004-12-10 Dermo Cosmologie Lab De COMPOSITION BASED ON DIOSGENINE APPLICABLE TOPICALLY
KR100899847B1 (en) * 2008-12-16 2009-05-27 주식회사 코스메카코리아 Cosmetic compositions for skin-whitening
KR101361848B1 (en) * 2011-12-16 2014-02-12 (주)모아캠 Method for Preparing Mucin from Dioscorea opposita and Cosmetic Composition Containing the Same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06219934A (en) * 1992-11-26 1994-08-09 Dowa Mining Co Ltd Skin-whitening cosmetic
KR970005271A (en) * 1995-07-25 1997-02-19 신태율 Cosmetic composition containing extract of an asteraceae
JPH10194947A (en) * 1997-01-13 1998-07-28 Tae Yuru Shin Cosmetic composition containing extract of plant of family cannabaceae
KR20030021811A (en) * 2001-09-07 2003-03-15 김진영 whitening

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06219934A (en) * 1992-11-26 1994-08-09 Dowa Mining Co Ltd Skin-whitening cosmetic
KR970005271A (en) * 1995-07-25 1997-02-19 신태율 Cosmetic composition containing extract of an asteraceae
JPH10194947A (en) * 1997-01-13 1998-07-28 Tae Yuru Shin Cosmetic composition containing extract of plant of family cannabaceae
KR20030021811A (en) * 2001-09-07 2003-03-15 김진영 whitening

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030061985A (en) * 2002-01-14 2003-07-23 (주)대덕바이오 Melanin synthesis inhibition compound and its composition containing stigmasterol
FR2855753A1 (en) * 2003-06-03 2004-12-10 Dermo Cosmologie Lab De COMPOSITION BASED ON DIOSGENINE APPLICABLE TOPICALLY
WO2004108064A3 (en) * 2003-06-03 2005-04-07 Dermo Cosmologie Lab De Diosgenin-based composition suitable for topical application
KR100899847B1 (en) * 2008-12-16 2009-05-27 주식회사 코스메카코리아 Cosmetic compositions for skin-whitening
KR101361848B1 (en) * 2011-12-16 2014-02-12 (주)모아캠 Method for Preparing Mucin from Dioscorea opposita and Cosmetic Composition Containing the Same

Similar Documents

Publication Publication Date Title
EP2335685A1 (en) Skin-whitening agent, anti-aging agent, and skin cosmetic
KR100702519B1 (en) Whitening composition comprising an extract of Broussonetia kazinoki var. humilis
KR101729209B1 (en) Development of skin-care products Based on Antioxidative effect of Abeliophyllum distichum Nakai
KR20080078753A (en) Method for extraction of antioxidants and cosmeceuticals from plant resources
KR101711002B1 (en) Manufacturing method for an extract of the leaf of panax ginseng, and the cosmetic composition including the extract
KR101474216B1 (en) Cosmetic compositions used for antiaging and antiwrinkle
KR100441596B1 (en) cosmetic composition containing plant extract complex
KR0180688B1 (en) Skin whitening composition using extracts from asparagus cochinchinensis merrill
KR20030025716A (en) Melanin synthesis inhibition compound and its composition contaning Dioscorea rhizoma extract
KR20020035656A (en) Inhibition agent of tyrosinase composed of saururus chinensis(lour) baill extract and cosmetic composition having whitening effect containing the same
KR101931654B1 (en) Method for preparing extract of fermented silkworm cocoon for antioxdidation and skin-whitening, and a cosmetic composition containing fermented extract of silkworm cocoon as an active ingredients
KR20090117364A (en) Cosmetic composition for whitening of the skin comprising the extract of brucea javanica as active ingredient
KR101686521B1 (en) Composition for beauty of skin
KR100463081B1 (en) Cosmetic compositions containing Phaseolus aureus extracts for skin whitening
KR100453217B1 (en) Skin whitener
KR101995220B1 (en) Composition for preventing, improving or treating skin wrinkle comprising Oxya chinensis sinuosa extract or compound isolated from the extract as effective component
KR100566857B1 (en) Cosmetic Composition of Lifting and Whitening Ingredient Containing Saponin extracted from Rhynchosia Molubilis
KR19990030419A (en) Extraction method of natural situation mushroom extract and manufacturing method of whitening cosmetics using the extract
KR101190201B1 (en) Cosmetic composition containing extract of pinus root
WO2008156330A1 (en) Use of xanthorrhizol for anti-wrinkle treatment
KR100585468B1 (en) Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper
KR100190989B1 (en) Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof
KR20190025329A (en) A cosmetic composition comprising salix gracilistyla extract
KR20030020811A (en) Whitening cosmetics containing natural extracts
KR101980144B1 (en) A composition for antioxidating, whitening and improving wrinkle comprising extracts of pleurotus salmoneostramineus

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application